Smartphone app to monitor active inflammatory bowel disease
Part of Digestive system clinical trials.
This study tests a smartphone app (SEMEIA) to help monitor people with active Crohn's disease or ulcerative colitis. It may help you track your symptoms and stay in touch with your doctor without needing as many office visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn's disease or ulcerative colitis that has been confirmed by a doctor.
- You are 18 years old or older.
- You are having symptoms right now that require your doctor to change your treatment (starting a new medicine, changing the dose, or adding another medicine).
- You can use a smartphone and an email address to enter data in a health app called SEMEIA.
- You are willing to take part in the study for 12 months.
- You have not had certain surgeries on your intestines or a stoma, and you are not pregnant now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether people with inflammatory bowel disease (IBD) can be safely monitored from home instead of visiting the hospital every few months. It uses a smartphone app and home tests to check your condition, with fewer in-person visits.
This study tests a smartphone app designed to help people with Crohn's disease feel better emotionally. You'll use the app at home, and researchers will see if it improves your wellbeing.
This Phase 4 study tests whether using the myIBDcoach smartphone app helps people with Crohn’s disease manage their care. It’s for people who are newly diagnosed or having a flare and have not used biologic medicines before.
This study aims to improve care and reduce health gaps for people with inflammatory bowel disease using text-message surveys to track symptoms and guide better disease management.
This trial tests a self-management program for people with active Crohn's disease or ulcerative colitis. It aims to improve quality of life by helping you better manage your condition.
This study tests if a mobile app can help manage your inflammatory bowel disease (IBD) from home. You may be eligible if you have IBD that has been active in the last two years and you are between 18 and 75 years old.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.